TABLE 1.
Baseline clinical characteristics of patients in different triglyceride-glucose (TyG) index groups.
| Variables | TyG < 8.41 mg/dl n = 3,315 |
8.41 ≤ TyG < 8.80 mg/dl n = 3,321 |
8.80 ≤ TyG < 9.25 mg/dl n = 3,317 |
TyG ≥ 9.25 mg/dl n = 3,318 |
P Valve |
| Age (year) | 61.04 ± 9.18 | 62.07 ± 8.61 | 62.51 ± 9.02 | 63.21 ± 10.74 | <0.001 |
| Male, n (%) | 2,322 (70.0%) | 2,375 (71.5%) | 2,324 (73.0%) | 2,422 (73.0%) | 0.035 |
| SBP (mmHg) | 128.50 (118.0, 145.0) | 131.8 (118.0, 150.0) | 136.9 (119.0, 155.0) | 139.0 (120.0, 156.0) | 0.038 |
| BMI (kg/m2) | 26.16 ± 3.68 | 26.17 ± 3.69 | 26.24 ± 3.70 | 26.95 ± 3.73 | 0.048 |
| LDL-C (mmol/L) | 2.44 (1.86, 2.96) | 2.45 (1.87, 2.95) | 2.46 (1.88, 2.96) | 2.50 (1.87, 2.98) | 0.191 |
| TC (mmol/L) | 4.02 (3.37, 4.87) | 4.27 (3.58, 5.08) | 4.47 (3.73, 5.32) | 5.33 (4.09, 6.08) | <0.001 |
| HDL-C (mmol/L) | 1.00 (0.91,1.28) | 1.05 (0.90, 1.66) | 1.15 (0.90, 1.86) | 1.19 (1.10, 2.24) | <0.001 |
| LP(a) (mmol/L) | 161.0 (85.0, 309.0) | 161 (86.0, 312.7) | 156.8 (86.5, 299.0) | 160.60 (87.0, 305.9) | 0.96 |
| TG (mmol/L) | 0.84 (0.70, 0.99) | 1.28 (1.11,1.46) | 1.79 (1.46, 2.09) | 2.81 (2.04, 4.09) | <0.001 |
| FPG (mmol/L) | 4.94 (4.57, 5.40) | 5.25 (4.79, 5.96) | 5.61 (4.98, 6.91) | 6.68 (5.23, 9.72) | <0.001 |
| SUA (mmol/L) | 305.3 (269.0, 398.0) | 326.5 (271.0, 406.0) | 348.1 (285.0, 423.0) | 355.8 (289.0, 440.0) | <0.001 |
| Creatinine (mmol/L) | 69.00 (59.86, 79.00) | 71.24 (60.00, 79.00) | 72.60 (60.01, 80.00) | 72.88 (61.0, 81.0) | 0.046 |
| WBC (10∧9/L) | 6.49 (5.26, 8.06) | 6.81 (5.60, 8.41) | 6.86 (5.56, 8.57) | 7.56 (5.68, 8.86) | <0.001 |
| Platelet (10∧9/L) | 198.0 (164.0, 242.7) | 203.0 (169.0, 243.0) | 214.0 (173.0, 246.0) | 218.6 (178.0, 251.0) | 0.005 |
| RBC (10∧9/L) | 4.00 (4.14, 4.79) | 4.05 (4.15, 4.90) | 4.35 (4.15, 4.99) | 4.59 (4.17, 5.10) | <0.001 |
| Current smoker, n (%) | 1,410 (42.5%) | 1,378 (41.5%) | 1,378 (41.5%) | 1,337 (40.3%) | 0.042 |
| Current drinker, n (%) | 760 (22.9%) | 731 (22.0%) | 737 (22.2%) | 666 (20.1%) | 0.009 |
| Statin use, n (%) | 2,801 (84.6%) | 2,766 (83.3%) | 2,752 (83.0%) | 2,770 (83.5%) | 0.197 |
| HTN, n (%) | 1,236 (37.3%) | 1,529 (46.0%) | 1,628 (49.1%) | 1,665 (50.2%) | <0.001 |
| Diabetes, n (%) | 309 (9.3%) | 560 (16.9%) | 888 (26.8%) | 1,456 (43.9%) | <0.001 |
| MRT, n (%) | 1,772 (53.5%) | 2,044 (61.5%) | 2,155 (65.0%) | 2,230 (67.2%) | <0.001 |
| Distribution of coronary atherosclerosis | |||||
| LCA, n (%) | 295 (8.9%) | 343 (10.3%) | 368 (11.1%) | 370 (11.2%) | 0.001 |
| LAD, n (%) | 2,124 (64.1%) | 2,336 (70.3%) | 2,403 (72.4%) | 2,502 (75.4%) | <0.001 |
| LCX, n (%) | 1,555 (46.9%) | 1,626 (49.0%) | 1,822 (54.9%) | 1,928 (58.1%) | <0.001 |
| RCA, n (%) | 1,791 (54.0%) | 1,979 (59.6%) | 2,073 (62.5%) | 2,129 (64.2%) | <0.001 |
BMI, body mass index; FPG, fasting plasma glucose; HDL-C, high density lipoprotein cholesterol; HTN, hypertension; LDL-C, low-density lipoprotein cholesterol; MRT, myocardial revascularization; RBC, red blood cell count; SBP, systolic blood pressure; SUA, serum uric acid; WBC, white blood cell count; TC, total cholesterol; TG, triglyceride; LCA, left coronary artery; LAD, left anterior descending; LCX, left circumflex artery; RCA, right coronary artery.